Quan Vu

Insider Reports History

Location
Woodland Hills, CA
Signature
/s/ Quan Vu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Quan Vu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ocugen, Inc. CFO/CBO Common Stock 165,934 $108,355 $0.6530 06 Mar 2023 Direct
Monopar Therapeutics Chief Financial Officer Common Stock 1,500 $104,925 $69.95 26 Dec 2025 Direct
180 Life Sciences Corp. COO / Chief Business Officer Common Stock 20,500 $3,854 $0.1880 16 Dec 2021 Direct
180 Life Sciences Corp. COO / Chief Business Officer Stock Option (Right to Buy) 275,000 08 Dec 2021 Direct
Monopar Therapeutics Chief Financial Officer Restricted Stock Units 9,826 02 Dec 2025 Direct
Monopar Therapeutics Chief Financial Officer Stock Options 7,135 02 Dec 2025 Direct

Insider Reports Filed by Quan Vu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNPR Monopar Therapeutics 26 Dec 2025 1 +$104,925 4 Chief Financial Officer 29 Dec 2025, 12:15
MNPR Monopar Therapeutics 02 Dec 2025 2 $0 4 Chief Financial Officer 08 Dec 2025, 16:47
MNPR Monopar Therapeutics 03 Mar 2025 1 $0 4 Chief Financial Officer 05 Mar 2025, 16:06
MNPR Monopar Therapeutics 03 Mar 2025 0 $0 3 Chief Financial Officer 05 Mar 2025, 16:05
OCGN Ocugen, Inc. 06 Mar 2023 0 $0 3 CFO/CBO 10 Mar 2023, 18:26
ATNF 180 Life Sciences Corp. 16 Dec 2021 1 +$31,840 4 COO / Chief Business Officer 16 Dec 2021, 16:00
ATNF 180 Life Sciences Corp. 10 Dec 2021 1 +$17,550 4 COO / Chief Business Officer 10 Dec 2021, 17:04
ATNF 180 Life Sciences Corp. 08 Dec 2021 1 $0 4 COO / Chief Business Officer 10 Dec 2021, 07:20
ATNF 180 Life Sciences Corp. 29 Oct 2021 0 $0 3 COO / Chief Business Officer 04 Nov 2021, 18:47